47.54 0.00 (0.00%)
After hours: 4:20PM EDT
|Bid||47.58 x 800|
|Ask||47.60 x 800|
|Day's Range||47.25 - 47.74|
|52 Week Range||32.22 - 48.68|
|Beta (3Y Monthly)||0.12|
|PE Ratio (TTM)||29.82|
|Forward Dividend & Yield||0.72 (1.54%)|
|1y Target Est||N/A|
LONDON , Sept. 10, 2019 /PRNewswire/ -- Smith+Nephew (LSE: SN, NYSE: SNN), the global medical technology business, is pleased to announce the US launch of the new PICO 7Y Single Use Negative Pressure Wound ...
LONDON , July 11, 2019 /PRNewswire/ -- Smith & Nephew (NYSE: SNN; LSE: SN), the global medical technology business, today announces the results of the first ever prospective clinical trial to evaluate ...
LONDON , June 5, 2019 /PRNewswire/ -- Smith & Nephew (LSE: SN, NYSE: SNN), the global medical technology business, has announced the launch of its CONQUEST FN™ system, a new implant solution to treat femoral ...
LONDON , May 22, 2019 /PRNewswire/ -- Smith & Nephew (LSE: SN, NYSE: SNN), the global medical technology business, today presented new data at the International Society for Pharmacoeconomics and Outcomes ...
LONDON , May 13, 2019 /PRNewswire/ -- Smith & Nephew (LSE: SN, NYSE: SNN), the global medical technology business, today announces the U.S. launch of the WEREWOLF™ FLOW 90 Wand with FLOW~IQ™ Technology. ...
Smith & Nephew , the global medical technology business, welcomes the launch of new medical technologies guidance from the UK National Institute for Health and Care Excellence .
WILMINGTON, Del., March 14, 2019 -- Rigrodsky & Long, P.A.: Do you own shares of Osiris Therapeutics, Inc. (NASDAQ GM: OSIR)? Did you purchase any of your shares prior to.
LONDON , March 13, 2019 /PRNewswire/ -- Smith & Nephew (LSE:SN, NYSE:SNN), the global medical technology business, today at the American Academy of Orthopaedic Surgeons annual meeting in Las Vegas presented ...
The two companies enter into a strategic collaboration for future development of technology for digital surgery across a broad range of clinical areas LONDON , March 12, 2019 /PRNewswire/ -- Brainlab, ...
LONDON, March 12, 2019 /PRNewswire/ -- Smith & Nephew (LSE: SN, NYSE: SNN), the global medical technology company, today announces product launches and investments that establish its multi-asset digital surgery and robotic ecosystem. "Smith & Nephew is making a long-term commitment to bring together advanced technologies in robotics, digital surgery, and machine learning as well as augmented reality to empower surgeons and improve clinical outcomes. Currently in development, NAVIO 7.0 is the next version of Smith & Nephew's handheld robotic surgical system.
Osiris Therapeutics, Inc. (OSIR), a regenerative medicine company focused on developing and marketing products for wound care, orthopedics, and sports medicine, today announced that it has entered into an agreement and plan of merger with Smith & Nephew plc pursuant to which Smith & Nephew will acquire Osiris for $19.00 per share in cash, a total of approximately $660.5 million in cash. Peter Friedli, Chairman of the Board and co-founder of Osiris, said, “This is a very good outcome for Osiris’ shareholders.
VANCOUVER, BC / ACCESSWIRE / March 4, 2019 / Sunniva Inc. ("Sunniva", the "Company", "we", "our" or "us") (SNN) (SNNVF), a North American provider of cannabis products and services, is pleased to announce that it has closed the second tranche of the Company's non-brokered offering (the "Financing") of convertible debentures ("Convertible Debentures") for an additional CAD $3,288,125 million, bringing total gross proceeds raised by the Financing to CAD $18,330,180 million. As previously disclosed, this Financing provides additional working capital for Sunniva to meet higher than anticipated near term sales demand for its branded cannabis products in California and for general corporate purposes.
MEMPHIS, Tenn. , Nov. 16, 2018 /PRNewswire/ -- Smith & Nephew (LSE: SN, NYSE: SNN), the global medical technology business, presented a number of compelling clinical outcomes around its flagship JOURNEY ...
LONDON , Oct. 17, 2018 /PRNewswire/ -- Smith & Nephew (LSE: SN, NYSE: SNN), the global medical technology business, today announced at the Orthopaedic Trauma Association Annual Meeting in Orlando, FL USA ...